Ever Source Wealth Advisors, LLC Vir Biotechnology, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $2.2 Billion
- Q3 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,107 shares of VIR stock, worth $6,232. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,107
Previous 1,548
28.49%
Holding current value
$6,232
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VIR
# of Institutions
243Shares Held
106MCall Options Held
246KPut Options Held
126K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$93.9 Million0.72% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$92.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$72.7 Million32.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$72.1 Million0.0% of portfolio
-
State Street Corp Boston, MA5.24MShares$29.5 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $747M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...